Intravitreal Aflibercept Injection in Vision Impairment Due to DME

Clinical trial NCT01331681 · COMPLETED

Trial details

NCT number: NCT01331681
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Macular Edema

Start date: 2011-05-09
Primary completion: 2013-06-03
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.